Header Logo

Connection

Vibhudutta Awasthi to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications Vibhudutta Awasthi has written about Xenograft Model Antitumor Assays.
  1. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. Br J Pharmacol. 2013 Dec; 170(7):1436-48.
    View in: PubMed
    Score: 0.104
  2. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase. Neoplasia. 2015 Jan; 17(1):43-54.
    View in: PubMed
    Score: 0.028
  3. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Mol Cancer Ther. 2011 Nov; 10(11):2146-56.
    View in: PubMed
    Score: 0.022
  4. Neem leaf extract induces radiosensitization in human neuroblastoma xenograft through modulation of apoptotic pathway. Anticancer Res. 2011 Jan; 31(1):161-70.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.